Corcept Therapeutics (CORT) Reaches $15.42 Formed H&S; Poage Bankshares (PBSK)’s Sentiment Is 1

Corcept Therapeutics Incorporated (NASDAQ:CORT) Logo

Poage Bankshares Inc (PBSK) investors sentiment decreased to 1 in 2017 Q4. It’s down -0.67, from 1.67 in 2017Q3. The ratio has dropped, as 3 investment professionals increased and started new positions, while 3 decreased and sold their equity positions in Poage Bankshares Inc. The investment professionals in our database reported: 774,426 shares, up from 756,832 shares in 2017Q3. Also, the number of investment professionals holding Poage Bankshares Inc in top ten positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 1 Increased: 2 New Position: 1.

Corcept Therapeutics Incorporated (CORT) formed H&S with $14.96 target or 3.00% below today’s $15.42 share price. Corcept Therapeutics Incorporated (CORT) has $1.77B valuation. The stock decreased 6.26% or $1.03 during the last trading session, reaching $15.42. About 1.16 million shares traded. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 52.11% since April 3, 2017 and is uptrending. It has outperformed by 40.56% the S&P500.

Investors sentiment decreased to 1.49 in 2017 Q4. Its down 0.47, from 1.96 in 2017Q3. It worsened, as 30 investors sold Corcept Therapeutics Incorporated shares while 42 reduced holdings. 40 funds opened positions while 67 raised stakes. 87.40 million shares or 21.46% more from 71.96 million shares in 2017Q3 were reported. Manufacturers Life Insur The owns 0% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 236,728 shares. Birchview Limited Partnership has invested 1.01% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Metropolitan Life Insurance New York reported 0.01% in Corcept Therapeutics Incorporated (NASDAQ:CORT). First Quadrant L P Ca accumulated 2,115 shares or 0% of the stock. Comerica Bank & Trust has invested 0.02% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Strs Ohio invested in 60,800 shares or 0% of the stock. Eidelman Virant Capital accumulated 40,000 shares or 0.42% of the stock. Hightower Advsrs owns 11,832 shares for 0% of their portfolio. Vanguard Group accumulated 0.01% or 9.37M shares. Jpmorgan Chase has 176,182 shares for 0% of their portfolio. State Of Wisconsin Investment Board holds 73,000 shares. California-based Globeflex L P has invested 0.78% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Bridgeway Cap Management Incorporated holds 0.01% or 36,300 shares in its portfolio. 67,900 were reported by Catalyst Advsr Ltd Liability Co. Ftb Advsrs Inc holds 19 shares.

Since December 8, 2017, it had 1 insider buy, and 4 insider sales for $386,120 activity. $125,323 worth of Corcept Therapeutics Incorporated (NASDAQ:CORT) was sold by FISHMAN ROBERT S. $155,102 worth of Corcept Therapeutics Incorporated (NASDAQ:CORT) shares were bought by GALA RENEE D.

Analysts await Corcept Therapeutics Incorporated (NASDAQ:CORT) to report earnings on May, 7. They expect $0.20 EPS, up 400.00% or $0.16 from last year’s $0.04 per share. CORT’s profit will be $22.97 million for 19.28 P/E if the $0.20 EPS becomes a reality. After $0.17 actual EPS reported by Corcept Therapeutics Incorporated for the previous quarter, Wall Street now forecasts 17.65% EPS growth.

Among 6 analysts covering Corcept Therapeutics (NASDAQ:CORT), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corcept Therapeutics had 10 analyst reports since February 2, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, October 11 by Piper Jaffray. The rating was maintained by FBR Capital on Tuesday, March 20 with “Buy”. Ladenburg Thalmann initiated Corcept Therapeutics Incorporated (NASDAQ:CORT) rating on Thursday, February 2. Ladenburg Thalmann has “Buy” rating and $14 target. Stifel Nicolaus maintained Corcept Therapeutics Incorporated (NASDAQ:CORT) on Friday, November 3 with “Buy” rating. On Thursday, August 24 the stock rating was maintained by Piper Jaffray with “Buy”. On Friday, September 8 the stock rating was maintained by Piper Jaffray with “Buy”. The stock has “Buy” rating by FBR Capital on Thursday, March 8.

Poage Bankshares, Inc. operates as a savings and loan holding firm for Town Square Bank that provides financial services to individuals, families, and businesses. The company has market cap of $67.76 million. The firm accepts various deposit products, including savings accounts, NOW and demand accounts, business checking accounts, certificates of deposits, money market accounts, and retirement accounts. It has a 64.35 P/E ratio. It also offers one-to-four family residential mortgage loans; commercial real estate and multi-family loans; commercial and industrial loans; consumer loans comprising new and used automobile and truck loans, recreational vehicle loans, and personal loans; home equity loans and lines of credit; commercial business loans; and construction and land loans.

Corcept Therapeutics Incorporated (NASDAQ:CORT) Institutional Positions Chart